Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients (MMCR)

This study has been terminated.
(Poor recruitment.)
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Ramesh Prasad, St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier:
NCT01213394
First received: September 28, 2010
Last updated: April 18, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)